Abstract
Perimenopause is often associated with varying levels of psychological distress. Research has identified this time as a period of increased risk for both depression and psychosis. However, we know that the majority of women do not experience these difficulties during perimenopause. This chapter examines the current research literature looking at the factors associated with mental health difficulties during perimenopause, including both protective factors and those associated with increased risk. Evidence has shown that some women have a hormonal vulnerability to mood disorders. However, this does not fully account for the phenomenon of perimenopausal depression or psychosis in and of itself. Rather, there appears to be a complex interplay between hormonal vulnerability, the psychosocial resources one has (coping skills and social support), their overall well-being (exercise and other lifestyle factors), and the demands on their coping resources (stressful life events). The complexity of the relationship between perimenopause and mental health means that there is a need to look beyond either as a sole explanation for psychiatric illness during midlife. The importance of a biopsychosocial approach to formulation of mental health difficulties in midlife is particularly evident when looking at treatment and prevention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aksu, H., Sevinçok, L., Kücük, M., Sezer, S. D., & Oğurlu, N. (2011). The attitudes of menopausal women and their spouses towards menopause. Clinical & Experimental Obstetrics & Gynecology, 38(3), 251–255.
Arpels, J. C. (1996). The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data. Journal of Reproductive Medicine, 41(9), 633–639.
Avis, N. E., Brambilla, D., McKinlay, J. B., & Vass, K. (1994). A longitudinal analysis of the association between menopause and depression: Results from the Massachusetts Women’s Health Study. Annals of Epidemiology, 4(3), 214–220.
Avis, N. E., Crawford, S., & McKinlay, S. M. (1997). Psychosocial, behavioural, and health factors related to menopause symptomatology. Women’s Health, 3, 103–120.
Avis, N. E., & McKinlay, S. M. (1991). A longitudinal analysis of women’s attitudes toward the menopause: Results from the Massachusetts Women’s Health Study. Maturitas, 13(1), 65–79.
Ballinger, S. (1985). Psychosocial stress and symptoms of menopause: A comparative study of menopause clinic patients and non-patients. Maturitas, 7, 315–327.
Barber, C. E. (1989). Transition to the empty nest. In S. J. Bahr & E. T. Peterson (Eds.), Ageing and the family (pp. 15–32). Lexington, MA: Health and Company.
Bess, K. D., Fisher, A. T., Sonn, C. C., & Bishop, B. J. (2002). Psychological sense of community: Theory, research and application. In A. T. Fisher, C. C. Sonn, & B. J. Bishop (Eds.), Psychological sense of community: Research, applications, and implications (pp. 3–24). New York, NY: Kluwer Academic/Plenum Publishers.
Binfa, L., Castelo-Branco, C., Blumel, J. E., Cancelo, M. J., Bonilla, H., Munoz, I., … Villega Rios, R. (2004). Influence of psycho-social factors on climacteric symptoms. Maturitas, 48, 425–431.
Bosworth, H. B., Bastian, L. A., Rimer, B. K., & Siegler, I. C. (2003). Coping styles and personality domains related to menopausal stress. Women’s Health Issues, 13(1), 32–38.
Bromberger, J. T., Assman, S. F., Avis, N. E., Schocken, M., Kravitz, H. M., & Cordal, A. (2003). Persistent mood symptoms in a multiethnic community cohort of pre- and peri-menopausal women. American Journal of Epidemiology, 158, 347–356. doi:10.1093/aje/kwg155.
Bromberger, J. T., Kravitz, H. M., Chang, Y. F., Cyranowski, J. M., Brown, C., & Matthews, K. (2011). Major depression during and after the menopausal transition: Study of women’s health across the nation (SWAN). Psychological Medicine, 41, 1879–1888. doi:10.1017/S003329171100016X.
Bromberger, J. T., Kravitz, H. M., Matthews, K., Youk, A., Brown, C., & Feng, W. (2009). Predictors of first lifetime episodes of major depression in midlife women. Psychological Medicine, 39, 55–64.
Bromberger, J. T., Meyer, P. M., Kravitz, H. M., Sommer, B., Cordal, A., Powell, L., … Sutton-Tyrrell, K. (2001). Psychological distress and natural menopause: A multiethnic community study. American Journal of Public Health, 91(9), 1435–1442.
Bromberger, J. T., Schott, L. L., Kravitz, H. M., Sowers, M. F., Avis, N. E., Gold, E. B., … Matthews, K. (2010). Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition. Archives General Psychiatry, 67(6), 598–607.
Brownson, R. C., Eyler, A. A., King, A. C., Brown, D. R., Shyu, Y. L., & Sallis, J. F. (2000). Patterns and correlates of physical activity among U.S. women 40 years and older. American Journal of Public Health, 90(2), 264–270.
Brugge, K. L., Kripke, D. F., Ancoli-Israel, S., & Garfinkel, L. (1989). The association of menopausal status and age with sleep disorders. Sleep Research, 18, 208.
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., … Poulton, R. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301(5631), 386–389.
Cassano, P., Soares, C. N., & Cusin, C. (2005). Antidepressant response and well-being in pre-, peri-, and postmenopausal women with major depressive disorder treated with fluoxetine. Psychotherapy and Psychosomatics, 74(6), 362–365.
Choi, H., Lee, D., Lee, K., Kim, H., & Ham, E. (2004). A structural model of menopausal depression in Korean women. Archives of Psychiatric Nursing, 18(6), 235–242.
Ciocca, D. R., & Vargas Roig, L. M. (1995). Estrogen receptors in human nontarget tissues: Biological and clinical implications. Endocrine Reviews, 16, 35–62.
Cohen, S. (1987). Social factors and depressive symptoms. Contemporary Psychology, 32(4), 360–362. doi:10.1037/027006.
Cohen, L. S., Soares, C. N., Poitras, J. R., Prouty, J., Alexander, A. B., & Shifren, J. L. (2003). Short-term use of estradiol for depression in perimenopausal and postmenopausal women: A preliminary report. American Journal of Psychiatry, 160, 1519–1522.
Cohen, L. S., Soares, C. N., Vitonis, A. F., Otto, M. W., & Harlow, B. L. (2006). Risk for new onset of depression during the menopausal transition: The Harvard study of moods and cycles. Archives of General Psychiatry, 63(4), 385–390. doi:10.1001/archpsyc.63.4.385.
Cohen, L. S., & Wise, P. M. (1988). Effects if estradiol on the diurnal rhythm of serotonin activity in microdissected brain areas of ovariectomized rats. Endocrinology, 122, 2619–2625.
Collaborative Group on Hormonal Factors in Breast Cancer. (1997). Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. The Lancet, 350(9084), 1047–1059.
Cooke, D. J., & Greene, J. G. (1981). Types of life events in relation to symptoms at the climacterium. Journal of Psychosomatic Research, 25(1), 5–11. http://dx.doi.org/10.1016/0022-3999%2881%2990078-7.
Daley, A. (2008). Exercise and depression: A review of reviews. Journal of Clinical Psychology in Medical Settings, 15(2), 140–147. http://dx.doi.org/10.1007/s10880-008-9105-z.
Davis, S. R. (2002). The effects of tibolone on mood and libido. Menopause, 9(3), 162–170.
Deeks, A. A., & McCabe, M. P. (2004). Well-being and menopause: An investigation of purpose in life, self-acceptance and social role in premenopausal, perimenopausal and postmenopausal women. Quality of Life Research, 13, 389–398.
Dennerstein, L., Dudley, E., & Guthrie, J. (2002). Empty nest or revolving door? A prospective study of women’s quality of life in midlife during the phase of children leaving and re-entering the home. Psychological Medicine, 32(3), 545–550. http://dx.doi.org/10.1017/S0033291701004810.
Dennerstein, L., Lehert, P., Burger, H., & Dudley, E. (1999). Mood and the menopausal transition. Journal of Nervous and Mental Disease, 187(11), 685–691.
Dennerstein, L., Lehert, P., Dudley, E., & Guthrie, J. (2001). Factors contributing to positive mood during the menopausal transition. Journal of Nervous and Mental Disease, 189(2), 84–89.
Dennerstein, L., Smith, A. M., Morse, C., Burger, H., Green, A., Hopper, J., & Ryan, M. (1993). Menopausal symptoms in Australian women. The Medical Journal of Australia, 159(4), 232–236.
Elavsky, S., & McAuley, E. (2005). Physical activity, symptoms, esteem, and life satisfaction during menopause. Maturitas, 52, 374–385.
Fink, G., & Summer, B. E. H. (1996). Oestrogen and mental state. Nature, 383, 306. doi:10.1038/383306a0.
Folkman, S. (1986). Dynamics of a stressful encounter: Cognitive appraisal, coping and encounter outcomes. Journal of Personality and Social Psychology, 50(5), 992–1003.
Folkman, S. (1997). Positive psychological states and coping with severe stress. Social Science & Medicine, 45, 1207–1221.
Folkman, S., & Lazarus, R. S. (1985). If it changes it must be a process: A study of emotion and coping during three stages of a college examination. Journal of Personality and Social Psychology, 48, 150–170.
Freeman, E. W. (2010). Associations of depression with the transition to menopause. Menopause, 17(4), 823–827.
Freeman, E. W., Sammel, M. D., Gracia, C. R., Kapoor, S., Lin, H., Liu, L., & Nelson, D. B. (2005). Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertility and Sterility, 83, 383–392.
Freeman, E. W., Sammel, M. D., Lin, H., Gracia, C. R., & Kapoor, S. (2008). Symptoms in the menopausal transition: Hormone and behavioural correlates. Obstetrics and Gynecology, 111(1), 127–136. doi:10.1097/01.AOG.0000295867.06184.b1.
Freeman, E. W., Sammel, M. D., Lin, H., & Nelson, D. B. (2006). Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry, 63(4), 375–382. doi:10.1001/archpsyc.63.4.375.
Freeman, E. W., Sammel, M. D., & Liu, L. (2004). Hormones and menopausal status as predictors of depression in women in transition to menopause. Archives of General Psychiatry, 61, 62–70.
Freeman, E. W., Sammel, M. D., Rinaudo, P. J., & Sheng, L. (2004). Premenstrual syndrome as a predictor of menopausal symptoms. Obstetrics & Gynecology, 103(5 pt 1), 960–966.
Fuh, J.-L., Wang, S.-J., Lee, S.-J., Lu, S.-R., & Juang, K.-D. (2006). A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas, 53(4), 447–453. http://dx.doi.org/10.1016/j.maturitas.2005.07.009.
Gibbs, Z., Lee, S., & Kulkarni, J. (Unpublished Manuscript). The role of coping styles in depression during perimenopause: Use of maladaptive coping styles predicts depressive symptoms in the menopausal transition.
Gibbs, Z., Lee, S., & Kulkarni, J. (2013). Factors associated with depression during the perimenopausal transition. Women’s Health Issues, 23(5), e301–e307.
Gold, E. B., et al. (2000). Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. American Journal of Epidemiology 152(5), 463–473.
Gold, E. B., Block, G., Crawford, S., Lachance, L., FitzGerald, G., Miracle, H., & Sherman, S. (2004). Lifestyle and demographic factors in relation to vasomotor symptoms: Baseline results from the study of women’s health across the nation. American Journal of Epidemiology, 159(12), 1189–1199.
Gold, E. B., Colvin, A., Avis, N., Bromberger, J., Greendale, G. A., Powell, L., … Matthews, K. (2006). Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of women’s health across the nation. American Journal of Public Health, 96(7), 1226–1235. doi: 10.2105/AJPH.2005.066936
Gracia, C. R., Sammel, M. D., Freeman, E. W., Lin, H., Langan, E., Kapoor, S., & Al, E. (2005). Defining menopausal status: Creation of a new definition to identify the early changes of the menopausal transition. Menopause, 12, 128–135.
Greene, J. G. (1983). Bereavement and social support at the climacteric. Maturitas, 5, 115–124.
Greene, J. G., & Cooke, D. J. (1980). Life Stress and symptoms at the climacterium. British Journal of Psychiatry, 136, 486–491.
Hardy, R., & Kuh, D. (2002). Change in psychological and vasomotor symptom reporting during the menopause. Social Science & Medicine, 55, 1975–1988.
Harlow, B. L., Cohen, L. S., Otto, M. W., Spiegelman, D., & Cramer, D. W. (1999). Prevalence and predictors of depressive symptoms in older perimenopausal women. Archives of General Psychiatry, 56, 418–424.
Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P. M., Rebar, R., … de Villiers, T. J. (2012). Executive summary of the stages of reproductive aging workshop + 10: Addressing the unfinished agenda of staging reproductive aging. Menopause: The Journal of the North American Menopause Society, 19(4), 1159–1168. doi: 10.1097/gme.0b013e31824d8f40
Harlow, B. L., Wise, L. A., Otto, M. W., Soares, C. N., & Cohen, L. S. (2003). Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause. Archives of General Psychiatry, 60, 29–36.
Hecht, E., & Mensh, I. N. (1975). Life’s ups and downs may leave you down and out. Contemporary Psychology, 20(8), 639–640. http://dx.doi.org/10.1037/0013564.
Holte, A., & Mikkelsen, A. (1991). The menopausal syndrome: A factor analytic replication. Maturitas, 13(3), 193–203. http://dx.doi.org/10.1016/0378-5122(91)90194-U.
Hunter, M. (1992). The South-East England longitudinal study of the climacteric and postmenopause. Maturitas, 14, 117–126.
Igarashi, M., Saito, H., Morioka, Y., Oiji, A., Nadaoka, T., & Kashiwakura, M. (2000). Stress vulnerability and climacteric symptoms: Life events, coping behavior, and severity of symptoms. Gynecologic & Obstetric Investigation, 49(3), 170–178.
Jiménez, L. J., & Pérez, S. G. (1999). The attitude of the woman in menopause and its influence on the climacteric. GinecologÃa Obstetricia de México, 67, 319–322.
Joffe, H., Fagioli, L. P., Koukopoulos, A., Viguera, A. C., Hirschberg, A., Nonacs, R., … Cohen, L. S. (2011). Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. Journal of Clinical Endocrinology and Metabolism, 96(7), 1044–1054.
Joffe, H., Hall, J. E., Soares, C. N., Hennen, J., Reilly, C. J., Carlson, K., & Cohen, L. S. (2002). Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause, 9, 392–398.
Joffe, H., Soares, C. N., Petrillo, L. F., Viguera, A. C., Somley, B. L., Koch, J. K., & Cohen, L. S. (2007). Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. Journal of Clinical Psychiatry, 64(6), 473–479.
Kafanelis, B. V., Kostanski, M., Komesaroff, P. A., & Stojanovska, L. (2009). Being in the script of menopause: Mapping the complexities of coping strategies. Qualitative Health Research, 19(1), 30–41. doi:10.1177/1049732308327352.
Kornstein, S. G., Schatzberg, A. F., Thase, M. E., Yonkers, K. A., McCullough, J. P., Keitner, G. I., … Keller, M. B. (2000). Gender differences in treatment response to sertraline versus imipramine in chronic depression. American Journal of Psychiatry, 157(9), 1445–1452.
Kornstein, S. G., Young, E. A., Harvey, A. T., Wisniewski, S. R., Barkin, J. L., Thase, M. E., … Rush, A. J. (2010). The influence of menopausal status and postmenopausal use of hormone therapy on presentation of major depression in women. Menopause, 17(4), 828–839. doi: 10.1097/gme.0b013e3181d770a8
Kraepelin, E., & Diefendorf, A. R. (1907). Clinical psychiatry: A textbook for students and physicians, abstracted and adapted from the 7th German edition of Kraepelin’s Lehrbuch der Psychiatrie (new ed., rev, and augmented). New York, NY: Macmillan.
Kronenberg, F. (1990). Hot flashes: Epidemiology and physiology. Annals of the New York Academy of Science, 592, 52–86.
Kulkarni, J., Fitzgerald, P., & Seeman, M. V. (2012). The clinical needs of women with schizophrenia. In D. Castle, D. Copolov, T. Wykes, & K. Mueser (Eds.), Pharmacological and psychosocial treatments in schizophrenia (pp. 183–201). London: Informa Healthcare.
Lazarus, R. S. (1991). Emotion and adaptation. In L. A. Pervin (Ed.), Handbook of personality: Theory and research (pp. 609–637). New York, NY: Guilford.
Lee, Y., & Kim, H. (2008). Relationships between menopausal symptoms, depression, and exercise in middle-aged women: A cross-sectional survey. International Journal of Nursing Studies, 45, 1816–1822.
Lokuge, S., Frey, B. N., Foster, J. A., Soares, C. N., & Steiner, M. (2011). Depression in women: Windows of vulnerability and new insights into the link between estrogen and serotonin. The Journal of Clinical Psychiatry, 72(11), e1563–e1569. doi:10.4088/JCP.11com07089.
Mahe, V., & Dumain, A. (2001). Oestrogen withdrawal associated psychoses. Acta Psychiatrica Scandinavica, 104, 323–331.
Matsuda, T., Nakano, Y., Kanda, T., Iwata, H., & Baba, A. (1991). Gonadal hormones affect the hypothermia induced by serotonin1A (5-HT1A) receptor activation. Life Sciences, 48(17), 1627–1632. http://dx.doi.org/10.1016/0024-3205(91)90122-R.
Miech, R. A., & Shanahan, M. J. (2000). Socioeconomic status and depression over the life course. Journal of Health and Social Behavior, 41(2), 162–176. http://dx.doi.org/10.2307/2676303.
Mirzaiinjmabadi, K., Anderson, D., & Barnes, M. (2006). The relationship between exercise, Body Mass Index and menopausal symptoms in midlife Australian women. International Journal of Nursing Practice, 12(1), 28–34.
Moline, M. L., Broch, L., Zak, R., & Gross, V. (2003). Sleep in women across the life cycle from adulthood through menopause. Sleep Medicine Reviews, 7(2), 155–177. http://dx.doi.org/10.1053/smrv.2001.0228.
Morrison, J. H., Brinton, R. D., Schmidt, P. J., & Gore, A. C. (2006). Estrogen, menopause, and the aging brain: How basic neuroscience can inform hormone therapy in women. Journal of Neuroscience, 26(41), 10332–10348. doi:10.1523/jneurosci.3369-06.2006.
Morse, C. A., Dudley, E., Guthrie, J., & Dennerstein, L. (1998). Relationships between premenstrual complaints and perimenopausal experiences. Journal of Psychosomatic Obstetrics & Gynecology, 19(4), 182–191.
Murrell, S. A., Himmelfarb, S., & Wright, K. (1983). Prevalence of depression and its correlates in older adults. American Journal of Epidemiology, 117(2), 173–185.
Ozturk, O., Eraslan, D., Mete, H. E., & Ozsener, S. (2006). The risk factors and symptomatology of perimenopausal depression. Maturitas, 55(2), 180–186. http://dx.doi.org/10.1016/j.maturitas.2006.02.001.
Parry, B. L. (2008). Perimenopausal depression. American Journal of Psychiatry, 165(1), 23–27. doi:10.1176/appi.ajp.2007.07071152.
Parry, B. L. (2010). Optimal management of perimenopausal depression. International Journal of Women’s Health, 2, 143–151.
Payne, J. L. (2003). The role of estrogen in mood disorders in women. International Review of Psychiatry, 15, 280–290. doi:10.1080/0954026031000136893.
Payne, J. L., Roy, P. S., Murphy-Eberenz, K., Weismann, M. M., Swartz, K. L., McInnis, M. G., … Potash, J. B. (2007). Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. Journal of Affective Disorders, 99(1–3), 221–229. Retrieved from http://dx.doi.org/10.1016/j.jad.2006.08.013
Payne, J. L., Teitelbaum, P. J., & Joffe, H. (2009). A reproductive subtype of depression: Conceptualizing models and moving toward etiology. Harvard Review of Psychiatry, 17(2), 72–86. doi:10.1080/10673220902899706.
Raup, J. L., & Myers, J. E. (1989). The empty nest syndrome: Myth or reality? Journal of Counseling & Development, 68(2), 180–183.
Reed, M. J., & Kloosterboer, H. J. (2004). Tibolone: A selective tissue estrogenic activity regulator (STEAR). Maturitas, 48(Supplement 1), 4–6.
Reed, S. D., Ludman, E. J., Newton, K. M., Grothaus, L. C., LaCroix, A. Z., Nekhlyudov, L., … Bush, T. (2009). Depressive symptoms and menopausal burden in the midlife. Maturitas, 62(3), 306–310.
Richards, M., Rubinow, D. R., Daly, R. C., & Schmidt, P. J. (2006). Premenstrual symptoms and perimenopausal depression. American Journal of Psychiatry, 163(1), 133–137. doi:10.1176/appi.ajp.163.1.133.
Riecher-Rössler, A. (2003). Oestrogens and schizophrenia. Current Opinion in Psychiatry, 16(2), 187–192.
Riecher-Rössler, A. (2005). Estrogens and schizophrenia. In N. Bergemann & A. Riecher-Rössler (Eds.), Estrogen effects in psychiatric disorders (pp. 31–52). Wien: Springer.
Risch, N., Herrell, R., Lehner, T., Liang, K. Y., Eaves, L., Hoh, J., … Merikangas, K. R. (2009). Interaction between the serotonin transporter gene (5-httlpr), stressful life events, and risk of depression: A meta-analysis. Journal of the American Medical Association, 301(23), 2462–2471. doi: 10.1001/jama.2009.878
Rostrosky, S. S., & Travis, C. B. (1996). Menopause research and the dominance of the biomedical model 1984-1994. Psychology of Women Quarterly, 20, 285–312.
Rubinow, D. R., Roca, C. A., & Schmidt, P. J. (2007). Estrogens and depression in women. In R. A. Lobo (Ed.), Treatment of the postmenopausal woman: Basic and clinical aspects. New York, NY: Elsevier.
Rubinow, D. R., Schmidt, P. J., & Roca, C. A. (1998). Estrogen-serotonin interactions: Implications for affective regulation. Biological Psychiatry, 44(9), 839–850. http://dx.doi.org/10.1016/S0006-3223(98)00162-0.
Schiff, I., Regestein, Q., Tulchinsky, D., & Ryan, K. J. (1979). Effects of estrogens on sleep and psychological state of hypogonadal women. Journal of the American Medical Association, 242(22), 2405–2407.
Schmidt, P. J., Haq, N., & Rubinow, D. R. (2004). A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. American Journal of Psychiatry, 161(12), 2238–2244. doi:10.1176/appi.ajp.161.12.2238.
Schmidt, P. J., Murphy, J., Haq, N., Rubinow, D. R., & Danaceau, M. (2004). Stressful life events, personal losses, and perimenopause-related depression. Archives of Women’s Mental Health, 7(1), 19–26.
Schmidt, P. J., Nieman, L., Danaceau, M. A., Tobin, M. B., Roca, C. A., Murphy, J. H., & Rubinow, D. R. (2000). Estrogen replacement in perimenopause-related depression: A preliminary report. American Journal of Obstetrics and Gynecology, 183(2), 414–420. Retrieved from http://dx.doi.org/10.1067/mob.2000.106004
Schmidt, P. J., Roca, C. A., Bloch, M., & Rubinow, D. R. (1997). The perimenopause and affective disorders. Seminars in Reproductive Endocrinology, 15(1), 91–100. doi:10.1055/s-2008-1067971.
Schmidt, P. J., & Rubinow, D. R. (1991). Menopause-related affective disorders: A justification for further study. American Journal of Psychiatry, 148(7), 844–852.
Seritan, A. L., Iosif, A. M., Park, J. H., DeatherageHand, D., Sweet, R. L., & Gold, E. B. (2010). Self-reported anxiety, depressive, and vasomotor symptoms: A study of perimenopausal women presenting to a specialized midlife assessment center. Menopause, 17(2), 410–415.
Soares, C. N., Almeida, O. P., Joffe, H., & Cohen, L. S. (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial. Archives of General Psychiatry, 58(6), 529–534.
Soares, C. N., Arsenio, H., Joffe, H., Bankier, B., Cassano, P., Petrillo, L. F., & Cohen, L. S. (2006). Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: Impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause, 13(5), 780–786.
Soares, C. N., Poitras, J. R., Prouty, J., Alexander, A. B., Shifren, J. L., & Cohen, L. S. (2003). Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. Journal of Clinical Psychiatry, 64(4), 473–479.
Soules, M. R., Sherman, S., Parrott, E., Rebar, R., Santoro, N., Utian, W., & Woods, N. (2001). Executive summary: Stages of reproductive aging workshop (STRAW). Climacteric, 4(4), 267–272.
Sternfeld, B., Quesenberry, C., & Husson, G. (1999). Habitual physical activity and menopausal symptoms. Journal of Women’s Health, 8, 115–123.
Stewart, D. E., & Boydell, K. M. (1993). Psychologic distress during menopause: Associations across the reproductive life cycle. International Journal of Psychiatry in Medicine, 23, 157–162.
Stotland, N. L. (2002). Menopause: Social expectations, women’s realities. Archives of Women’s Mental Health, 5(1), 5–8. doi:10.1007/s007370200016.
Sumner, B. E. H. (1995). Estrogen increases the density of 5-hydroxytryptamine2A receptors in cerebral cortex and nucleus accumbens in the female rat. The Journal of Steroid Biochemistry and Molecular Biology, 54(1–2), 15. http://dx.doi.org/10.1016/0960-0760(95)00075-B.
Swegle, J. M., & Kelly, M. W. (2004). Tibolone: A unique version of hormone replacement therapy. Annals of Pharmacotherapy, 38(5), 874–881. doi:10.1345/aph.1D462.
Tam, L. W., Stucky, V., Hanson, R. E., & Parry, B. L. (1999). Prevalence of depression in menopause: A pilot study. Archives of Women’s Mental Health, 2(4), 175–181.
Thurston, R., Joffe, H., Soares, C. N., & Harlow, B. L. (2006). Physical activity and risk of vasomotor symptoms in women with and without a history of depression: Results from the Harvard study of moods and cycles. Menopause, 13, 553–560.
Timur, S., & Sahin, N. H. (2010). The prevalence of depression symptoms and influencing factors among perimenopausal and postmenopausal women. Menopause, 17(3), 545–551.
Veeninga, A. T., & Kraaimaat, F. W. (1989). Life stress and symptoms in menopause clinic patients and non-patients. Journal of Psychosomatic Obstetrics & Gynecology, 10(3), 269–277. doi:10.3109/01674828909016700.
Whiteman, M. K., Staropoli, C. A., Benedict, J. C., Borgeest, C., & Flaws, J. A. (2003). Risk factors for hot flashes in midlife women. Journal of Women’s Health, 12, 459–472.
Wilbur, J., Dan, A., Hedricks, C., & Holm, K. (1990). The relationship among menopausal status, menopausal symptoms, and physical activity in midlife women. Family and Community Health, 13, 67–78.
Woods, N. F., & Mitchell, E. S. (1996). Patterns of depressed mood in midlife women: Observations from the Seattle midlife women’s health study. Research in Nursing and Health, 19, 111–123.
Woods, N. F., & Mitchell, E. S. (1997). Pathways to depressed mood for midlife women: Observations from the Seattle midlife women’s health study. Research in Nursing and Health, 20, 119–129.
Woods, N. F., Smith-DiJulio, K., Percival, D. B., Tao, E. Y., Mariella, A., & Mitchell, E. S. (2008). Depressed mood during the menopausal transition and early postmenopause: Observations from the Seattle midlife women’s health study. Menopause: The Journal of The North American Menopause Society, 15(3), 223–232.
Worsley, R., Davis, S. R., Gavrilidis, E., Gibbs, Z., Lee, S., Burger, H., & Kulkarni, J. (2012). Hormonal therapies for new onset and relapsed depression during perimenopause. Maturitas, 73(2), 127–133. doi: 10.1016/j.maturitas.2012.06.011
Writing Group for the Women’s Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women’s health initiative randomized controlled trial. Journal of the American Medical Association, 288(3), 321–333. doi:10.1001/jama.288.3.321.
Zweifel, J. E., & O’Brien, W. H. (1997). A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology, 22(3), 189–212.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gibbs, Z., Kulkarni, J. (2014). Risk Factors for Depression During Perimenopause. In: Barnes, D. (eds) Women's Reproductive Mental Health Across the Lifespan. Springer, Cham. https://doi.org/10.1007/978-3-319-05116-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-05116-1_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-05115-4
Online ISBN: 978-3-319-05116-1
eBook Packages: Humanities, Social Sciences and LawSocial Sciences (R0)